Evidence map›Paper›PMID 34216838›Full record

Trial reportBone2021

Bone turnover marker responses to sleep restriction and weekend recovery sleep.

Christopher M Depner, John D Rice, Emma J Tussey, Robert H Eckel, Bryan C Bergman, Janine A Higgins, Edward L Melanson, Wendy M Kohrt, Kenneth P Wright, Christine M Swanson

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Bone, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Sleep Disruption and Bone Health.Current osteoporosis reports · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Christopher M DepnerSleep and Chronobiology Laboratory, Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA; Department of Health and Kinesiology, University of Utah, Salt Lake City, UT, USA.
John D RiceDepartment of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Aurora, CO, USA.
Emma J TusseyDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Robert H EckelDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Bryan C BergmanDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Janine A HigginsDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Edward L MelansonDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus, and Eastern Colorado VA Geriatric, Research, Education, and Clinical Center (GRECC), Aurora, CO, USA.
Wendy M KohrtDivision of Geriatric Medicine, University of Colorado Anschutz Medical Campus, and Eastern Colorado VA Geriatric, Research, Education, and Clinical Center (GRECC), Aurora, CO, USA.
Kenneth P WrightSleep and Chronobiology Laboratory, Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Christine M SwansonDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Christine.Swanson@CUAnschutz.edu.
University of Colorado Anschutz Medical Campus · USGeriatric Research Education and Clinical Center · USUniversity of Colorado Boulder · USColorado School of Public Health · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS · 1995 to 2026
$32.6M
The Collaboration Linking Opioid Use Disorder and Sleep ("CLOUDS") StudyU01HL150596 · NHLBI · YALE UNIVERSITY · PI BARRY, DECLAN T., REDEKER, NANCY S · 2019 to 2024
$5.1M
HIV-1, Insufficient Sleep and Vascular Endothelial DysfunctionR01HL131458 · NHLBI · UNIVERSITY OF COLORADO · PI CONNICK, ELIZABETH, DESOUZA, CHRISTOPHER A · 2016 to 2019
$3.0M
Sleep and Blood Pressure-Related Endothelial AbnormalitiesR01HL135598 · NHLBI · UNIVERSITY OF COLORADO · PI DESOUZA, CHRISTOPHER A, STAUFFER, BRIAN L · 2017 to 2020
$3.0M
Metabolic Effects of Sleep Extension in People with ObesityR01DK115502 · NIDDK · WASHINGTON UNIVERSITY · PI KLEIN, SAMUEL · 2018 to 2022
$2.9M
Sensitivity of the Circadian Clock to Light in Early ChildhoodR01HD087707 · NICHD · UNIVERSITY OF COLORADO · PI WRIGHT, KENNETH P · 2017 to 2021
$2.9M
Adaptive responses to overfeeding and weight regain in reduced obese individualsR01DK114272 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BESSESEN, DANIEL HOLLAND · 2018 to 2022
$2.5M
Metabolic and Cognitive Consequences of Sleep LossR01HL109706 · NHLBI · UNIVERSITY OF COLORADO · PI WRIGHT, KENNETH P · 2011 to 2014
$2.3M
Biomarkers and Altered Metabolic Pathways during Sleep Loss and Circadian DisruptionK01HL145099 · NHLBI · UNIVERSITY OF UTAH · PI DEPNER, CHRISTOPHER MICHAEL · 2019 to 2023
$888k
Sleep Disturbance: A Novel Risk Factor for Impaired Bone RemodelingK23AR070275 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SWANSON, CHRISTINE M · 2016 to 2020
$853k
Bone Turnover Responses to Sleep Restriction and Subsequent Sleep RecoveryR03AR074509 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SWANSON, CHRISTINE M · 2020 to 2021
$153k
NCATS NIH HHS UL1 TR002535NHLBI NIH HHS K01 HL145099NHLBI NIH HHS R01 HL109706NHLBI NIH HHS R01 HL131458NHLBI NIH HHS R01 HL135598NHLBI NIH HHS U01 HL150596NIAMS NIH HHS K23 AR070275NIAMS NIH HHS R03 AR074509NICHD NIH HHS R01 HD087707NIDDK NIH HHS F32 DK111161NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK114272NIDDK NIH HHS R01 DK115502
6 · The paper itself

Abstract

backgroundPrior data demonstrated three weeks of sleep restriction and concurrent circadian disruption uncoupled bone turnover markers (BTMs), indicating decreased bone formation and no change or increased bone resorption. The effect of insufficient sleep with or without ad libitum weekend recovery sleep on BTMs is unknown.

methodsBTMs were measured in stored serum from 20 healthy adults randomized to one of three study groups consisting of a control group (N = 3 men; 9 h/night) or one of two nocturnal sleep restriction groups in an inpatient laboratory environment. One Sleep Restriction group ("SR"; N = 9; 4 women) had 5 h sleep opportunity per night for nine nights. The other sleep restriction group had an opportunity for ad libitum Weekend Recovery sleep ("WR"; N = 8; 4 women) after four nights of 5 h sleep opportunity per night. Food intake was energy balanced at baseline and ad libitum thereafter. Fasted morning BTM levels and hourly 24 h melatonin levels were obtained on study days 3 (baseline), 5 (after 1 night of sleep restriction for WR and SR), and 11 (after a sleep restricted workweek with weekend recovery sleep in WR or 7 nights of sleep restriction in SR). Linear mixed-effects modeling was used to examine the effect of study duration (e.g., change over time), study condition, age, and sex on BTMs. Pearson correlations were used to determine associations between changes in BTMs and changes in weight and morning circadian misalignment (i.e., duration of high melatonin levels after wake time).

resultsThere was no significant difference between the three study groups in change over time (p ≥ 0.4 for interaction between assigned group and time for all BTMs), adjusted for age and sex. There was no significant change in N-terminal propeptide of procollagen type I (P1NP), osteocalcin, or C-telopeptide of type I collagen (CTX) from baseline to day 11 (all p ≥ 0.3). In women <25 years old, there was a non-significant decline in P1NP from day 3 to day 5 (= -15.74 ± 7.80 ng/mL; p = 0.06). Change in weight and morning circadian misalignment from baseline to day 11 were correlated with statistically non-significant changes in BTMs (all p ≤ 0.05).

conclusionIn this small secondary analysis, we showed that nine nights of prescribed sleep restriction with or without weekend recovery sleep and ad libitum food intake did not alter BTMs. It is possible that age, sex, weight change and morning circadian misalignment modify the effects of sleep restriction on bone metabolism.

Indexed as

Bone RemodelingSleepAdultBiomarkersCollagen Type IFemaleHumansMaleOsteocalcinSleep DeprivationBiomarkersCollagen Type IOsteocalcinBone metabolismBone turnover markersCircadian phaseRecovery sleepSleep restriction

Identifiers

PMID34216838
PMCPMC8316414
OpenAlexW3174293472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.